Skip to content

Latest medicine updates

196 updates found

New New Updated Updated Retired Retired

NARROW IT DOWN

MEDICINE NAME

CHANGES

Date range

DOCUMENT TYPE

STATUS

Pil
pantoprazole sodium sesquihydrate
Updated 27-Jul-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision
Pil
ondansetron hydrochloride dihydrate
Updated 27-Jul-17
Updated
  • Change to section 6 - date of revision
  • Change to section 3 - dose and frequency
  • Change to section 4 - how to report a side effect
Pil
hepatitis a vaccine, typhoid vaccine
Updated 27-Jul-17
Updated
  • Change to section 6 - date of revision
  • Change to name of medicinal product
Pil
olmesartan medoxomil
Updated 27-Jul-17
Updated
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Change to section 2 - use in children/adolescents
SPC
Evoxil (levofloxacin) 250mg film-coated tablets
levofloxacin hemihydrate
Retired 27-Jul-17
Beacon Pharmaceuticals
Retired
  • Product/presentation currently not marketed
SPC
Evoxil (levofloxacin) 5mg/ml solution for infusion
levofloxacin hemihydrate
Retired 27-Jul-17
Beacon Pharmaceuticals
Retired
  • Product/presentation currently not marketed
Pil
olanzapine
Updated 27-Jul-17
Updated
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
SPC
Evoxil (levofloxacin) 500mg film-coated tablets
levofloxacin hemihydrate
Retired 27-Jul-17
Beacon Pharmaceuticals
Retired
  • Product/presentation currently not marketed
Pil
finasteride
Updated 27-Jul-17
New
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
SPC
abatacept
Updated 27-Jul-17
Updated
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text
  • Change to section 4.8 - Undesirable effects - how to report a side effect
Pil
nevirapine
Updated 27-Jul-17
New
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Pil
tranylcypromine sulfate
Updated 27-Jul-17
Updated
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision
  • Change to section 2 - excipient warnings
SPC
aciclovir
Updated 27-Jul-17
Updated
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 10 - Date of revision of the text
SPC
aciclovir
Updated 27-Jul-17
Updated
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 10 - Date of revision of the text
Pil
montelukast sodium
Updated 27-Jul-17
Updated
  • Change to section 6 - date of revision
SPC
human insulin
Updated 27-Jul-17
Updated
  • Change to section 10 - Date of revision of the text
SPC
human insulin
Updated 27-Jul-17
Updated
  • Change to section 10 - Date of revision of the text
SPC
human insulin
Updated 27-Jul-17
Updated
  • Change to section 10 - Date of revision of the text
SPC
human insulin
Updated 27-Jul-17
Updated
  • Change to section 10 - Date of revision of the text
SPC
human insulin
Updated 27-Jul-17
Updated
  • Change to section 10 - Date of revision of the text
SPC
human insulin
Updated 27-Jul-17
Updated
  • Change to section 10 - Date of revision of the text
SPC
human insulin
Updated 27-Jul-17
Updated
  • Change to section 10 - Date of revision of the text
Pil
montelukast sodium
Updated 27-Jul-17
Updated
  • Change to section 6 - date of revision
SPC
human insulin
Updated 27-Jul-17
Updated
  • Change to section 10 - Date of revision of the text
SPC
human insulin
Updated 27-Jul-17
Updated
  • Change to section 10 - Date of revision of the text
SPC
human insulin
Updated 27-Jul-17
Updated
  • Change to section 10 - Date of revision of the text
Pil
montelukast sodium
Updated 27-Jul-17
Updated
  • Change to section 6 - date of revision
SPC
ramipril
Updated 27-Jul-17
Updated
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text
Pil
modafinil
Updated 27-Jul-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 6 - date of revision
  • Change to section 3 - how to take/use
  • Change to section 3 - duration of treatment
  • Change to section 4 - how to report a side effect
Pil
aciclovir
Updated 27-Jul-17
Updated
  • Change to section 2 - driving and using machines
  • Change to section 6 - date of revision
Pil
aciclovir
Updated 27-Jul-17
Updated
  • Change to section 2 - driving and using machines
  • Change to section 6 - date of revision
Pil
ramipril
Updated 27-Jul-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 6 - date of revision
Pil
phenindione
Updated 27-Jul-17
Updated
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - what you need to know - contraindications
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 6 - date of revision
  • Change to section 1 - what the product is
SPC
atovaquone, proguanil hydrochloride
Updated 27-Jul-17
Updated
  • Change to section 6.3 - Shelf life
  • Change to section 10 - Date of revision of the text
SPC
temozolomide
Updated 27-Jul-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
ispaghula husk
Updated 27-Jul-17
Updated
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
Pil
desloratadine
Updated 27-Jul-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Change to section 2 - excipient warnings
SPC
tranylcypromine sulfate
Updated 27-Jul-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 6.1 - List of excipients
Pil
prednisolone
Updated 27-Jul-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Pil
ropinirole hydrochloride
Updated 27-Jul-17
Updated
  • Removal of one or more presentations from joint PIL
Pil
mirtazapine
Updated 27-Jul-17
Updated
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Pil
diamorphine hydrochloride
Updated 27-Jul-17
Updated
  • Change to section 6 - date of revision
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number
Pil
tramadol hydrochloride
Updated 27-Jul-17
Updated
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
SPC
fluconazole
Updated 27-Jul-17
Updated
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Fertility, pregnancy and lactation
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text
SPC
escitalopram oxalate
Updated 27-Jul-17
Updated
  • Change to section 10 - Date of revision of the text
SPC
doxazosin mesilate
Updated 27-Jul-17
Updated
  • Change to section 6.3 - Shelf life
  • Change to section 10 - Date of revision of the text
SPC
efavirenz
Updated 27-Jul-17
Updated
  • Change to section 10 - Date of revision of the text
SPC
escitalopram oxalate
Updated 27-Jul-17
Updated
  • Change to section 10 - Date of revision of the text
Pil
mirtazapine
Updated 27-Jul-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision
SPC
finasteride
Updated 27-Jul-17
Updated
  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text

Page 1 of 4 Next

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue